Gerald A. Faich - Concepedia

Author

Gerald A. Faich

Center for Biologics Evaluation and Research

Also Known As

G A Faich, G Faich, G. A. FAICH, G. A. Faich, G. Faich, G.A. FAICH, G.A. Faich, GERALD A. FAICH, GERALD FAICH, Gerald A Faich

105

Publications

6.8K

Citations

H-Index

124

Concepts

All Affiliations

Center for Biologics Evaluation and Research University of Pennsylvania United States Food and Drug Administration Massachusetts General Hospital Pfizer (United States)

About

Gerald A. Faich is an author at Center for Biologics Evaluation and Research specializing in medicine, public health, and patient safety.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	32	2K
2	Public Health	15	19	885
3	Allergy	2	2	116
4	Allergy Medicine	1	1	75
5	Child Development	1	1	19

Gerald A. Faich

Publications

6.3K

Citations

H-Index

Page 1

	Year	Citations
Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis Fred E. Silverstein, Gerald A. Faich, Jay L. Goldstein, JAMA	2000	3.2K
Comparison of thromboembolic events in patients treated with Celecoxib, a Cyclooxygenase-2 specific inhibitor, versus Ibuprofen or Diclofenac William B. White, Gerald A. Faich, Andrew Whelton, The American Journal of Cardiology ThrombosisVenous ThrombosisThromboembolic EventsPharmacologyAnticoagulant	2002	231
Adverse-Drug-Reaction Monitoring Gerald A. Faich New England Journal of Medicine Drug SafetyDrug HypersensitivityU.s. FoodHealth PolicyMedicine	1986	230
THE EPIDEMIOLOGY OF DIABETIC ACIDOSIS: A POPULATION-BASED STUDY Gerald A. Faich, Howard Fishbein, Susan E. Ellis American Journal of Epidemiology Metabolic SyndromeDiabetes ManagementPopulation-based StudyDiabetes EpidemiologyRhode Island	1983	214
Administration of Parenteral Iron and Mortality among Hemodialysis Patients Harold I. Feldman, Marshall M. Joffe, Bruce Robinson, Journal of the American Society of Nephrology HemodialysisIron AdministrationRenal FunctionIron MetabolismMaintenance Hd	2004	194
AN EPIDEMIOLOGIC STUDY OF THE RISKS ASSOCIATED WITH PERIPHERAL INTRAVENOUS CATHETERS Ira B. Tager, MICHAEL B. GINSBERG, Susan E. Ellis, American Journal of Epidemiology	1983	194
Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib**The investigators had full access to the data and complete control over the design, conduct analysis, interpretation, and description of the study. The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or in writing the report. The views expressed are those of the investigators alone. William B. White, Gerald A. Faich, Jeffrey Borer, The American Journal of Cardiology RheumatologyThrombosisConduct AnalysisCardiovascular DiseaseMedicine	2003	175
Iron Administration and Clinical Outcomes in Hemodialysis Patients Harold I. Feldman, Jill Santanna, Wensheng Guo, Journal of the American Society of Nephrology	2002	145
Effect of onychomycosis on quality of life L A Drake, R K Scher, Edward B. Smith, Journal of the American Academy of Dermatology MedicineQuality Of LifeLife AssessmentClinical Mycology	1998	141
Comparative Mortality Associated With Ziprasidone and Olanzapine in Real-World Use Among 18,154 Patients With Schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC) Brian L. Strom, Sybil M. Eng, Gerald A. Faich, American Journal of Psychiatry	2010	120

Page 1